The global demand for Prebiotics For Infant Formula Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Prebiotics for infant formula is specially designed to stimulate the growth of lactobacillus and bifidobacteria. Bifidobacteria is the main prebiotic that is found in the intestinal tract of breastfeeding babies. These supplements are designed after the oligosaccharides that are found in human milk. Prebiotics can be a safe addition to the baby's diet unless the baby is born prematurely or immunocompromised. Prebiotics for infant formula promotes healthy gut bacteria growth, support the immune system, and stimulate bowel movements.
Market Dynamics
The increasing birth of premature babies and rising number C-section surgeries are the fundamental drivers for the market growth of prebiotics for infant formula. Additionally, rising awareness regarding the consumption of prebiotics and the health benefits of prebiotics for infants is also assumed to be one of the major driving forces for the market growth of prebiotics for infant formula. Moreover, the continuous production of prebiotics and the increasing disposable incomes of the consumers are expected to aid the market growth of prebiotics for infant formula. Increased adoption of prebiotics due to lifestyle changes will also boost the market growth. The positive impact of prebiotics on the immune system of infants is further estimated to flourish the market growth of prebiotics for infant formula.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of prebiotics for infant formula. The growth and trends of prebiotics for infant formula industry provide a holistic approach to this study.
Market Segmentation
This section of the prebiotics for infant formula market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Human Milk Oligosaccharides (HMOS)
- Galactooligosaccharides (GOS)
- Fructooligosaccharides (FOS)
- Mannan-oligosaccharides (MOS)
- Polydextrose (PDX)
- Lactulose (LOS)
- Inulin
By Source
- Bacteria
- Algae
- Fungi
- Plants & Vegetables
- Others
By Grade
By Form
By Product Type
- Standard Formula
- Special Formula
- Follow Up Formula
- Toddler Formula
By Infant Age
- 0-6 Months
- 6-12 Months
- 1-3 years
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Prebiotics For Infant Formula market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Prebiotics For Infant Formula Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the prebiotics for infant formula market include Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., and Südzucker AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.